Efficacy of intramammary infusion of ceftiofur hydrochloride at drying off for treatment and prevention of bovine mastitis during the nonlactating period

Veterinary Therapeutics

Volumn 7, Issue 1, 2006, Pages 35-42

  Hallberg, J W ^a   Wachowski, M ^a   Moseley, W M ^a   Dame, K J ^a   Meyer, J ^a   Wood, S L ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; INJECTION; LACTATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UDDER;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHALOSPORINS; DRUG ADMINISTRATION SCHEDULE; FEMALE; INJECTIONS; LACTATION; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; TREATMENT OUTCOME;

BOS TAURUS; BOVINAE;

EID: 33645956768     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Oliver SP, Sordillo LM: Approaches to the manipulation of mammary involution. J Dairy Sci 72:1647-1664, 1989.
2. Neave FK, Dodd FH, Henriques E: Udder infections in the 'dry period.' J Dairy Res 17:37-49, 1950.
3. Leslie KE, Dingwell RT: Background to dry cow therapy: What, where, why - Is it still relevant? Proc Natl Mastitis Council:5-17, 2003.
4. Oliver SP, Mitchell BA: Susceptibility of bovine mammary gland to infections during the dry period. J Dairy Sci 66:1162-1166, 1983.
5. Smith KL, Todhunter DA, Schoenberger PS: Environmental pathogens and intramammary infection during the dry period. J Dairy Sci 68:402-417, 1985.
6. Smith KL, Todhunter DA, Schoenberger PS: Environmental mastitis: Cause, prevalence, prevention. J Dairy Sci 68(6):1531-1553, 1985.
7. Eberhart RJ: Management of dry cows to reduce mastitis. J Dairy Sci 69:1721-1729, 1986.
8. Oliver SP: Frequency of isolation of environmental mastitis-causing pathogens and incidence of new intramammary infection during the nonlactating period. Am J Vet Res 49:1789-1793, 1988.
9. Oliver SP, Sordillo LM: Udder health in the periparturient period. J Dairy Sci 71:2584-2606, 1988.
10. Hornish RE, Kotarski SF: Cephalosporins in veterinary medicine - Ceftiofur use in food animals. Curr Top Med Chem 2(7):717-731, 2002.
11. Salmon SA, Watts JL, Yancey RJ: In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance. J Vet Diagn Invest 8:332-336, 1996.
12. Oliver SP, Gillespie BE, Ivey SJ, et al: Efficacy of extended ceftiofur therapy for treatment of naturally occurring subclinical mastitis in lactating dairy cows. J Dairy Sci 87:2393-2400, 2004.
13. Oliver SP, Almeida RA, Gillespie BE, et al: Efficacy of extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis intramammary infections in lactating dairy cattle. J Dairy Sci 87:3322-3329, 2004.
14. Hallberg JW, Wachowski MB, Alaniz GR, et al: Efficacy for intramammary formulations of pirlimycin hydrochloride, ceftiofur hydrochloride, and ceftiofur crystalline free acid as dry cow therapies. Proc 2nd Int Symp Mastitis Milk Quality: 263-267, 2001.
15. United States Food and Drug Administration/Center for Veterinary Medicine: Good Target Animal Study Practices, Clinical Investigators and Monitors. Rockville, MD, FDA/CVM, 1996.
16. Committee for Veterinary Medicinal Products. Working Party on the Efficacy of Veterinary Medicines: Clinical Trials to Assess the Efficacy of Veterinary Medicinal Products Administered via the Teat Duct to Lactating Cows for the Treatment of Subclinical Mastitis. III/3173/ 92-EN, Final. London, European Medicines Agency, 1993.
17. Hogan JS, Gonzalez R, Harmon RJ, et al: Laboratory Handbook on Bovine Mastitis. Madison, WI, National Mastitis Council, 1999.
18. SAS Institute Inc. SAS/STAT User's Guide, Version 8. SAS Institute, Cary, NC, 1999.